Skip to main content
. 2022 Apr 20;12(19):12011–12052. doi: 10.1039/d2ra00067a

α-Glucosidase inhibitory activity of divalent metal complexes bearing hydrazide ligands.

Entry Compounds Structure number IC50 (μM) Ref.
1 graphic file with name d2ra00067a-u1.jpg L1 NA 53 a
graphic file with name d2ra00067a-u2.jpg L2 NA
graphic file with name d2ra00067a-u3.jpg L3 47.51
graphic file with name d2ra00067a-u4.jpg L4 NA
graphic file with name d2ra00067a-u5.jpg L5 NA
graphic file with name d2ra00067a-u6.jpg L6 396.35
graphic file with name d2ra00067a-u7.jpg L7 NA
graphic file with name d2ra00067a-u8.jpg L8 240 54 b
graphic file with name d2ra00067a-u9.jpg L9 230
graphic file with name d2ra00067a-u10.jpg L10 Not reported clearly 55 b
2 53 a
2a graphic file with name d2ra00067a-u11.jpg
1 = [Zn(L1)2]Cl2 1 X = N; Y = C; R1 = H; R2 = H 101.29
2 = [Zn(L2)2]Cl2 2 X = C; Y = N; R1 = H; R2 = H 56.27
3 = [Zn(L3)2]Cl2 3 X = C–NO2; Y = C; R1 = H; R2 = H 27.71
4 = [Zn(L4)2]Cl2 4 X = C; Y = C; R1 = H; R2 = NO2 97.26
5 = [Zn(L5)2]Cl2 5 X = C; Y = C–NH2; R1 = H; R2 = H NA
6 = [Zn(L6)2]Cl2 6 X = C; Y = C; R1 = Br; R2 = H 121.19
2b graphic file with name d2ra00067a-u12.jpg
9 = [Cu(L1)2]Cl2 9 X = N; Y = C; R1 = H; R2 = H >500
10 = [Cu(L2)2]Cl2 10 X = C; Y = N; R1 = H; R2 = H 17.73
11 = [Cu(L3)2]Cl2 11 X = C–NO2; Y = C; R1 = H; R2 = H 1.15
12 = [Cu(L4)2]Cl2 12 X = C; Y = C; R1 = H; R2 = NO2 18.91
13 = [Cu(L5)2]Cl2 13 X = C; Y = C–NH2; R1 = H; R2 = H 0.15
14 = [Cu(L6)2]Cl2 14 X = C; Y = C; R1 = Br; R2 = H 0.21
15 = [Cu(L7)2]Cl2 15 X = C; Y = C; R1 = H; R2 = Cl NA
2c graphic file with name d2ra00067a-u13.jpg
22 = [Co(L1)2]Cl2 22 X = N; Y = C; R1 = H; R2 = H NA
23 = [Co(L2)2]Cl2 23 X = C; Y = N; R1 = H; R2 = H 66.48
24 = [Co(L3)2]Cl2 24 X = C–NO2; Y = C; R1 = H; R2 = H 153.23
25 = [Co(L4)2]Cl2 25 X = C; Y = C; R1 = H; R2 = NO2 96.95
26 = [Co(L5)2]Cl2 26 X = C; Y = C–NH2; R1 = H; R2 = H NA
27 = [Co(L6)2]Cl2 27 X = C; Y = C; R1 = Br; R2 = H 213.30
28 = [Co(L7)2]Cl2 28 X = C; Y = C; R1 = H; R2 = Cl NA
2d graphic file with name d2ra00067a-u14.jpg
30 = [Mn(L1)2]Cl2 30 X = N; Y = C; R1 = H; R2 = H 45.63
31 = [Mn(L2)2]Cl2 31 X = C; Y = N; R1 = H; R2 = H 143.21
32 = [Mn(L3)2]Cl2 32 X = C–NO2; Y = C; R1 = H; R2 = H 345.62
33 = [Mn(L4)2]Cl2 33 X = C; Y = C; R1 = H; R2 = NO2 NA
34 = [Mn(L5)2]Cl2 34 X = C; Y = C–NH2; R1 = H; R2 = H NA
35 = [Mn(L7)2]Cl2 35 X = C; Y = C; R1 = H; R2 = Cl 457.28
3 54 b
3a graphic file with name d2ra00067a-u15.jpg
7 = [Zn(L8)2]·2H2O 7 180
3b graphic file with name d2ra00067a-u16.jpg
M(ii) = Cu, Ni
16 = [Cu(L8)2(OH2)2]·H2O 16 140
19 = [Ni(L8)2(OH2)2]·H2O 19 200
3c graphic file with name d2ra00067a-u17.jpg
8 = [Zn(L9)CH3COO]·H2O 8 190
3d graphic file with name d2ra00067a-u18.jpg
M(ii) = Cu, Ni
17 = [Cu(L9)2(OH2)2]·H2O 17 170
20 = [Ni(L9)2(OH2)2]·H2O 20 230
4 graphic file with name d2ra00067a-u19.jpg 55 b
M(ii) = Cu, Ni, Co, Mn
18 = [Cu(L10)2] 18 Not reported clearly
21 = [Ni(L10)2] 21 Not reported clearly
29 = [Co(L10)2] 29 Not reported clearly
36 = [Mn(L10)2] 36 Not reported clearly
a

Acarbose as the reference drug (IC50 = 378.25 μM).

b

Acarbose as the reference drug (IC50 = 99 μM).